Tri-Cira 21 0.215 mg

TRI-CIRA 21 0.215 MG is an oral contraceptive tablet containing norgestimate. It is commonly used for birth control and may help regulate menstrual cycles. This medication is manufactured by Apotex Inc. in Canada.

TRI-CIRA 21 0.215 MG is primarily used as a hormonal contraceptive to prevent pregnancy. It works by inhibiting ovulation and altering the cervical mucus to prevent sperm from reaching the egg. Some individuals also use norgestimate for managing menstrual irregularities or symptoms of polycystic ovary syndrome (PCOS).

Common effects of TRI-CIRA 21 0.215 MG may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users may experience nausea, breast tenderness, or headaches. These effects vary among individuals and typically subside as the body adjusts to the medication.

It is important to use TRI-CIRA 21 0.215 MG as directed by a healthcare provider. This medication should not be used during pregnancy or while breastfeeding. Individuals with a history of blood clots, liver disease, or certain cancers should consult a healthcare provider before use. Always follow the prescribed guidelines for optimal safety.

TRI-CIRA 21 0.215 MG may interact with certain medications, including antibiotics, anticonvulsants, and HIV medications. Alcohol consumption should be moderated, as it can affect the effectiveness of the medication. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.